Nurix Therapeutics is seeking a Head of Investigative Toxicology to establish and lead its in-house in vitro toxicology testing capability. Reporting to the Senior Vice President, Nonclinical Toxicology, this hands-on, lab-based leadership role will build the assays, infrastructure, and mechanistic understanding needed to identify target- and modality-related safety liabilities earlier in discovery, reduce reliance on external CROs for early screening, and inform lead selection and optimization across targeted protein degrader programs. The role partners closely with Discovery Biology, Chemistry, DMPK, and Pharmacology. The position will establish and validate an in vitro toxicology platform, develop assays using primary and immortalized cell culture, hepatocyte and iPSC cardiomyocyte models, and set the technical roadmap for capabilities to build internally versus source through CRO partners. It will also lead day-to-day laboratory operations, including equipment, vendors, reagents, and data management. As the in vitro/investigative toxicology representative on discovery teams, the role will design and interpret mechanistic studies, including assessment of neosubstrate and off-target degradation risk. The Director will translate findings into risk assessments and recommendations for candidate selection and lead optimization, communicate with research leadership, and hire, mentor, and develop scientific staff as the function grows.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree